Pachyonychia Congenita Fund Salt Lake City, UT - 84109

Pachyonychia Congenita Fund is categorized under Medical Research in Salt Lake City, UT and active since 2003.

Pachyonychia Congenita Fund was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.

If you are seeking more information, feel free to contact Mary Schwartz at the company’s single location by writing to 2386 East Heritage Way # B, Salt Lake City, Utah UT 84109 or by phoning (877) 628-7300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pachyonychia Congenita Fund
Contact Person: Mary Schwartz
Address: 2386 East Heritage Way # B, Salt Lake City, Utah 84109
Phone Number: (877) 628-7300
Website Address: pachyonychia.org
Annual Revenue (USD): $100.000 to $499.999
Founded: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 541720
Share This Business:

Pachyonychia Congenita Fund was started in 2003 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Mary Schwartz for inquiries that concern Pachyonychia Congenita Fund by calling the company number (877) 628-7300, as your correspondence is most welcome. Additionally, the physical location of the single location of Pachyonychia Congenita Fund can be found at the coordinates 40.711173,-111.821731 as well as the street address 2386 East Heritage Way # B in Salt Lake City, Utah 84109.

For its online presence, you may visit Pachyonychia Congenita Fund’s website at pachyonychia.org and engage with its social media outlets through on Twitter and on Facebook.